North America Compression Therapy Market
市场规模（十亿美元）
CAGR :
% 
USD
125.04 Million
USD
320.54 Million
2024
2032
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 125.04 Million |
 Market Size (Forecast Year) |
USD 320.54 Million |
 CAGR |
% |
| Major Markets Players |
|
北美壓力療法市場細分：技術（靜態壓力療法、動態壓力療法）、產品（壓力服、壓力膠帶、壓力泵、壓力支架、壓力泵）、應用（靜脈曲張治療、深靜脈血栓形成治療、淋巴水腫治療、腿部潰瘍治療、其他）、最終用戶（藥店和零售商、醫院和診所、電子商務平台）——行業趨勢及預測（至 2032 年）
壓迫療法市場規模
- 2024 年北美壓力療法市場價值為1.2504 億美元，預計到 2032 年將達到3.2054 億美元，預測期內複合年增長率為 3.8%。
- 慢性靜脈疾病（如慢性靜脈功能不全 (CVI)、靜脈曲張和深部靜脈栓塞 (DVT)）的盛行率日益增加，這推動了對有效壓迫療法解決方案的需求。
北美壓力療法市場分析
- 壓迫療法在各種靜脈和淋巴疾病的治療中發揮關鍵作用，包括慢性靜脈功能不全 (CVI)、深部靜脈栓塞 (DVT)、淋巴水腫和靜脈曲張。繃帶、彈性襪、氣動加壓裝置和繃帶等壓迫產品有助於改善血液循環、減輕腫脹並預防靜脈疾病的進展。這些解決方案廣泛應用於醫院、復健中心、家庭護理機構和專科診所。
- 北美地區對壓力療法的需求主要源於以下因素：慢性靜脈疾病發生率上升、老年人口增長，且老年人口易患血管疾病，以及人們對早期幹預和非侵入性治療益處的認識不斷提高。此外，肥胖和糖尿病（均為靜脈功能不全的主要危險因子）的盛行率不斷上升，也進一步推動了市場擴張。
- 北美是壓力治療市場的領先地區，得益於其完善的醫療基礎設施、先進醫療技術的早期應用以及優惠的報銷政策。美國佔據主導地位，這得益於其龐大的血管疾病患者群體、日益增長的門診量以及對家庭醫療保健和可穿戴醫療設備的強勁投資。
- 美國壓力療法市場也受到監管部門審批的影響，包括FDA對創新且用戶友善的壓力設備的批准。此外，醫療保健支出的不斷增長、對行動和便攜式治療解決方案的需求不斷增長，以及智慧紡織品和基於感測器的壓力服的進步，正在提高患者的依從性和治療效果。市場也見證了個人化和數據驅動治療方法的日益普及，這些方法支持長期疾病管理和生活品質的改善。
報告範圍壓力療法市場區隔
|
屬性 |
壓力療法關鍵市場洞察 |
|
涵蓋的領域 |
|
|
覆蓋國家 |
北美洲
|
|
主要市場參與者 |
|
|
市場機會 |
|
|
加值資料資訊集 |
除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括進出口分析、生產能力概覽、生產消費分析、價格趨勢分析、氣候變遷情景、供應鏈分析、價值鏈分析、原材料/消耗品概覽、供應商選擇標準、PESTLE 分析、波特分析和監管框架。 |
壓力療法市場趨勢
“智慧布料與數位健康融合”
- 壓力療法技術的進步——例如智慧壓力服、穿戴式感測器和數控氣動加壓裝置——正在透過即時監測壓力水平、依從性和治療效果，徹底改變患者護理。這些創新在淋巴水腫和下肢靜脈潰瘍等慢性疾病的治療中尤其有效，能夠提高治療的精確度和舒適度。
- 例如，美國間歇性氣動加壓 (IPC) 裝置和梯度加壓服的採用率顯著增加，這得益於臨床指南建議在醫院和家庭護理環境中使用這些裝置來預防 DVT
- 人工智慧解決方案和行動健康應用程式正越來越多地與壓力治療系統集成，以製定個人化治療方案、追蹤患者依從性並提醒臨床醫生注意併發症的早期跡象。這些數位工具正在簡化護理協調，增強患者參與度，並在臨床和家庭護理環境中推動更好的長期療效。
壓力療法市場動態
司機
“靜脈疾病盛行率上升和壓迫裝置技術進步”
- 北美壓迫療法市場正在經歷顯著增長，這主要得益於慢性靜脈功能不全 (CVI)、靜脈曲張、淋巴水腫和深部靜脈栓塞 (DVT) 的發病率不斷上升，尤其是在老化和糖尿病人群中。
- 技術創新——例如間歇性氣動壓縮 (IPC) 設備、梯度壓縮服裝和帶有整合感測器的智慧紡織品——正在透過增強舒適度、即時監控和個人化壓力控制來改善治療效果。
- 美國和加拿大政府推出的健康計劃提倡預防性護理、靜脈疾病的早期診斷以及慢性病的家庭管理，這推動了整個醫療保健領域對先進壓力療法產品的需求。
- 壓迫治療設備與數位健康平台和電子健康記錄 (EHR) 的結合正在提高治療依從性、遠端監控和患者參與度，從而加速其應用。
例如，
- 根據美國靜脈論壇 (2024) 的統計，美國超過 40% 的成年人患有慢性靜脈疾病，這凸顯了對方便有效的壓迫療法的迫切需求。
- 2024 年 3 月，3M 健康護理在北美推出了下一代壓縮包，具有可調節張力指示器和抗菌層，可增強臨床和家庭環境中的易用性和感染控制。
- 對非侵入性、經濟高效的治療方案的持續關注以及對穿戴式健康解決方案日益增長的偏好，進一步推動了北美地區對先進壓縮療法產品的採用。
機會
“數位健康整合與家庭壓迫療法的擴展”
- 向數位化醫療服務和分散式患者管理的轉變為北美採用便攜式和聯網壓迫治療解決方案開闢了新的機會。
- 智慧壓縮服裝和行動壓縮泵的需求正在不斷增長，它們可用於家庭護理環境、長期護理機構和遠端監控計劃，從而將護理服務擴展到農村和服務不足的人群。
- 遠距醫療平台的發展推動了與行動應用程式同步的壓縮設備的發展，使臨床醫生能夠遠端監控治療依從性、壓力水平和治療進展。
例如，
- 2024 年 2 月，加拿大衛生藥物和技術局 (CADTH) 強調在社區淋巴水腫管理計畫中越來越多地實施智慧壓迫治療工具。
- Bio Compression Systems 和 Tactile Medical 等公司推出了適合家庭使用的應用程式型 IPC 設備，提供遠端追蹤和臨床醫生回饋功能。
- 醫療保健提供者專注於減少醫院再入院率和改善慢性病護理結果，這加速了家庭治療模式的採用。
- 此外，基於雲端的平台和人工智慧分析的日益普及使得跨多站點醫療保健網路的壓迫治療計劃更加精確和個性化。
克制/挑戰
“產品成本高，報銷範圍有限”
- 北美壓力療法市場面臨的一大挑戰是高端壓力產品（尤其是先進的氣動壓力設備和智慧穿戴系統）的高成本。這些產品需要大量的前期投資，這使得低收入患者和小型醫療機構難以獲得這些產品。
- 不同付款人和不同省份的壓力療法報銷政策差異很大，某些設備的報銷範圍有限，尤其是在家庭環境中使用時，從而造成了獲取和採用方面的差異。
例如，
- 根據美國靜脈學會 2024 年的一份報告，除非患者符合嚴格的臨床標準，否則美國許多私人保險公司不會完全承保智慧壓縮服或家用 IPC 設備，從而延誤了早期幹預。
- 在加拿大，各省淋巴水腫覆蓋計畫的差異導致患者無法獲得治療級壓縮解決方案。
- 遵守 FDA 和加拿大衛生部等機構的安全和性能標準也增加了新產品的複雜性和上市時間。
壓力療法市場範圍
根據技術、產品、應用和最終用戶，市場分為四個顯著的部分。
|
分割 |
細分 |
|
依技術 |
|
|
按產品
|
|
|
按應用
|
|
|
按最終用戶 |
|
2025 年，靜態壓縮療法預計將佔據市場主導地位，在技術領域佔據最大份額
靜態壓迫療法 因其高普及率和對精準度的需求，預計在2025年佔據壓迫療法市場的最大份額，達到37.82%。這種主導地位的驅動力源自於人們越來越青睞易於使用、經濟高效且可靠的壓迫解決方案，用於治療靜脈曲張、淋巴水腫和慢性靜脈功能不全等疾病。
預計靜脈曲張治療將在預測期內佔據應用市場的最大份額
預計到2025年，靜脈曲張治療領域將佔據市場主導地位，市佔率高達31.11%，這得益於其高盛行率和精準治療的需求。這歸因於靜脈曲張盛行率的上升，尤其是在老化和肥胖族群中。對非侵入性、經濟高效的治療方案（例如壓力襪和繃帶）的需求成長，將進一步推動該領域的成長。
壓力療法市場區域分析
“美國是壓力療法市場的主導國家”
- 美國在北美壓迫療法市場佔據主導地位，佔據最大份額，這得益於其完善的醫療保健基礎設施、早期採用創新醫療技術以及專門從事血管和淋巴水腫護理的關鍵市場參與者的強大影響力。
- 慢性靜脈功能不全、靜脈曲張和淋巴水腫等靜脈疾病的盛行率很高，再加上老年人和糖尿病患者的不斷增長，推動了臨床和家庭護理環境中靜態和動態壓迫治療解決方案的使用率的提高。
- 3M Health Care、Tactile Medical 和 Bio Compression Systems 等大公司總部都設在美國，提供各種經 FDA 批准、技術先進的壓縮設備，旨在改善治療效果和患者依從性。
- 政府主導的預防保健、慢性病管理和家庭治療舉措，以及對壓力服裝和設備的優惠報銷政策，進一步鞏固了美國在北美壓力療法市場的領導地位。
“預計加拿大將實現最高成長率”
- 預計加拿大將在北美壓力療法市場中實現最快的成長。該國公共資助的醫療保健體系，加上對慢性病預防和社區護理的日益重視，正在推動壓力療法解決方案的普及。
- 各省級衛生部門在淋巴水腫、靜脈潰瘍和深部靜脈血栓等疾病管理方面的策略性投入，正在加速靜態和動態壓迫療法的應用。人們對早期介入和非侵入性治療方案的認識不斷提高，也進一步推動了相關需求。
- 隨著加拿大多學科診所、復健中心和家庭醫療保健服務的不斷擴張，對方便易用、經濟實惠、適用於臨床和家庭的壓力產品的需求日益旺盛。衛生部、病患權益組織和學術機構之間的合作也促進了壓力療法技術的研究和創新。
壓力療法市場佔有率
市場競爭格局按競爭對手提供詳細資料。詳細資訊包括公司概況、公司財務狀況、收入、市場潛力、研發投入、新市場計劃、北美業務、生產基地和設施、生產能力、公司優勢和劣勢、產品發布、產品寬度和廣度以及應用主導地位。以上提供的數據點僅與公司在市場方面的重點相關。
市場中主要的市場領導者有：
- 3M醫療保健（美國）
- Tactile Medical（美國）
- Bio Compression Systems, Inc.（美國）
- Medi USA（德國/美國）
- Sigvaris 集團（瑞士/美國）
- ArjoHuntleigh Inc.（瑞典）
- BSN Medical（Essity）（德國）
- JUZO（Julius Zorn Inc.）（德國/美國）
- Paul Hartmann AG（德國）
- Thuasne集團（法國）
北美壓力療法市場的最新發展
- 2023年10月，Medi GmbH & Co. 推出了 Medi Rehab，這是一款壓力襪，提供大腿襪和小腿襪版本，並配有露趾和閉趾設計。露趾設計的小腿襪尤其適用於踝關節損傷或跟腱斷裂的保守治療或術後治療，方便舒適地穿脫。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA COMPRESSION THERAPY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET APPLICATION COVERAGE GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
4.3 COST ANALYSIS BREAKDOWN
4.4 HEALTHCARE ECONOMY
4.4.1 HEALTHCARE EXPENDITURE
4.4.2 CAPITAL EXPENDITURE
4.4.3 CAPEX TRENDS
4.4.4 CAPEX ALLOCATION
4.4.5 FUNDING SOURCES
4.4.6 INDUSTRY BENCHMARKS
4.4.7 GDP RATIO IN OVERALL GDP
4.4.8 HEALTHCARE SYSTEM STRUCTURE
4.4.9 GOVERNMENT POLICIES
4.4.10 ECONOMIC DEVELOPMENT
4.5 INDUSTRY INSIGHTS
4.5.1 MICRO AND MACRO ECONOMIC FACTORS
4.5.2 PENETRATION AND GROWTH PROSPECT MAPPING
4.5.3 KEY PRICING STRATEGIES
4.6 INNOVATION TRACKER AND STRATEGIC ANALYSIS
4.6.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
4.6.1.1 JOINT VENTURES
4.6.1.2 MERGERS AND ACQUISITIONS
4.6.1.3 LICENSING AND PARTNERSHIP
4.6.1.4 TECHNOLOGY COLLABORATIONS
4.6.1.5 STRATEGIC DIVESTMENTS
4.6.2 NUMBER OF PRODUCTS IN DEVELOPMENT
4.6.3 STAGE OF DEVELOPMENT
4.6.4 TIMELINES AND MILESTONES
4.6.5 INNOVATION STRATEGIES AND METHODOLOGIES
4.6.6 RISK ASSESSMENT AND MITIGATION
4.6.7 FUTURE OUTLOOK
4.7 OPPORTUNITY MAP ANALYSIS
4.8 PATENT ANALYSIS –
4.8.1 PATENT QUALITY AND STRENGTH
4.8.2 PATENT FAMILIES
4.8.3 LICENSING AND COLLABORATIONS
4.8.4 COMPETITIVE LANDSCAPE
4.8.5 IP STRATEGY AND MANAGEMENT
4.8.6 OTHER OBSERVATIONS
4.9 REIMBURSEMENT FRAMEWORK
4.1 SUPPLY CHAIN ECOSYSTEM
4.10.1 PROMINENT COMPANIES
4.10.2 SMALL & MEDIUM SIZE COMPANIES
4.10.3 END USERS
4.11 TECHNOLOGY ROADMAP
4.12 TARIFFS & IMPACT ON THE MARKET
4.12.1 CURRENT TARIFF RATE(S) IN TOP-5 COUNTRY MARKETS
4.13 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE
4.14 VENDOR SELECTION CRITERIA DYNAMICS
4.15 IMPACT ON SUPPLY CHAIN
4.15.1 RAW MATERIAL PROCUREMENT
4.15.2 MANUFACTURING AND PRODUCTION
4.15.3 LOGISTICS AND DISTRIBUTION
4.15.4 PRICE PITCHING AND POSITION OF MARKET
4.16 INDUSTRY PARTICIPANTS: PROACTIVE MOVES
4.16.1 SUPPLY CHAIN OPTIMIZATION
4.16.2 JOINT VENTURE ESTABLISHMENTS
4.17 IMPACT ON PRICES
4.18 REGULATORY INCLINATION
4.18.1 GEOPOLITICAL SITUATION
4.18.2 TRADE PARTNERSHIPS BETWEEN COUNTRIES
4.18.2.1 FREE TRADE AGREEMENTS:
4.18.2.2 ALLIANCES ESTABLISHMENTS:
4.18.3 STATUS ACCREDITATION (INCLUDING MFTN)
4.18.4 DOMESTIC COURSE OF CORRECTION
4.18.4.1 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS:
4.18.4.2 ESTABLISHMENT OF SPECIAL ECONOMIC ZONES / INDUSTRIAL PARKS:
4.19 PRICE INDEX
5 REGULATORY FRAMEWORK
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF CHRONIC VENOUS DISORDERS GLOBALLY
6.1.2 TECHNOLOGICAL ADVANCEMENTS AND PRODUCT INNOVATION
6.1.3 INCREASING SPORTS INJURIES & ACCIDENTS
6.1.4 INCREASING AWARENESS OF THERAPY BENEFITS
6.2 RESTRAINTS
6.2.1 LIMITED REIMBURSEMENT AND INSURANCE COVERAGE
6.2.2 AVAILABILITY OF ALTERNATIVE TREATMENT
6.3 OPPORTUNITIES
6.3.1 GROWTH IN HOME BASED THERAPY
6.3.2 POST-SURGICAL CARE & REHABILITATION
6.3.3 RISING LIFESTYLE-RELATED DISEASES
6.4 CHALLENGES
6.4.1 LACK OF STANDARDIZED THERAPY PROTOCOLS
6.4.2 ENSURING ACCURATE PRODUCT FIT AND CORRECT APPLICATION
7 NORTH AMERICA COMPRESSION THERAPY MARKET, BY PRODUCT TECHNIQUE
7.1 OVERVIEW
7.2 STATIC COMPRESSION THERAPY
7.2.1 COMPRESSION STOCKINGS
7.2.2 COMPRESSION BANDAGES
7.2.3 COMPRESSION SLEEVES
7.2.4 COMPRESSION WRAPS
7.2.5 COMPRESSION GLOVES/GAUNTLETS
7.3 DYNAMIC COMPRESSION THERAPY
7.3.1 PNEUMATIC COMPRESSION DEVICES
7.3.2 ADAPTIVE COMPRESSION THERAPY DEVICES
8 NORTH AMERICA COMPRESSION THERAPY MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 COMPRESSION BANDAGES
8.2.1 SHORT STRETCH BANDAGES
8.2.2 LONG STRETCH BANDAGES
8.2.3 MULTILAYER COMPRESSION BANDAGES
8.3 COMPRESSION GARMENTS FOR LYMPHEDEMA
8.3.1 LEG GARMENTS
8.3.2 ARM SLEEVES
8.3.3 HAND GLOVES
8.3.4 TORSO/TRUNK GARMENTS
8.3.5 FACE/HEAD GARMENTS
8.4 COMPRESSION STOCKINGS FOR VENOUS DISEASES
8.4.1 BELOW KNEE STOCKINGS
8.4.2 THIGH HIGH STOCKINGS
8.4.3 PANTYHOSE/FULL LEG STOCKINGS
8.4.4 MATERNITY STOCKINGS
8.5 COMPRESSION WRAPS
8.6 PNEUMATIC COMPRESSION DEVICES
8.7 COMPRESSION HOSIERY & GAUNTLETS
9 NORTH AMERICA COMPRESSION THERAPY MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 VARICOSE VEINS
9.3 LYMPHEDEMA
9.4 CHRONIC VENOUS INSUFFICIENCY (CVI)
9.5 DEEP VEIN THROMBOSIS (DVT)
9.6 VENOUS LEG ULCERS
9.7 WOUND CARE
9.8 SPORTS INJURY MANAGEMENT
10 NORTH AMERICA COMPRESSION THERAPY MARKET, BY PATIENT GROUP
10.1 OVERVIEW
10.2 ADULT
10.3 GERIATRIC
10.4 PEDIATRIC
11 NORTH AMERICA COMPRESSION THERAPY MARKET, BY COMPRESSION LEVEL
11.1 OVERVIEW
11.2 MODERATE COMPRESSION
11.3 STRONG COMPRESSION
11.4 MILD COMPRESSION
11.5 VERY STRONG COMPRESSION
12 NORTH AMERICA COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNELS
12.1 OVERVIEW
12.2 HOSPITALS
12.2.1 BANDAGES
12.2.2 POST-OPERATIVE COMPRESSION STOCKINGS
12.2.3 PNEUMATIC COMPRESSION DEVICES
12.3 RETAIL PHARMACIES
12.3.1 MILD TO MODERATE COMPRESSION STOCKINGS
12.3.2 COMPRESSION BANDAGES
12.3.3 SLEEVES AND GAUNTLETS
12.4 ECOMMERCE PLATFORMS
12.4.1 COMPRESSION STOCKINGS & GARMENTS
12.4.2 COMPRESSION WRAPS
12.4.3 SLEEVES, GLOVES, AND SOCKS
12.4.4 PORTABLE PNEUMATIC DEVICES
12.5 SPECIALTY CLINICS
12.5.1 HIGH-PRESSURE COMPRESSION GARMENTS
12.5.2 PNEUMATIC COMPRESSION PUMPS
12.5.3 CUSTOM WRAPS
12.6 MEDICAL DEVICE STORES
12.6.1 COMPRESSION STOCKINGS
12.6.2 COMPRESSION BANDAGES
12.6.3 COMPRESSION WRAPS
12.6.4 PNEUMATIC COMPRESSION DEVICES
12.6.5 ADAPTIVE COMPRESSION SYSTEMS
12.7 HOME HEALTHCARE PROVIDERS
12.7.1 COMPRESSION WRAPS
12.7.2 SLEEVES & GARMENTS
12.7.3 BANDAGES
12.7.4 PNEUMATIC PUMPS (PORTABLE)
12.8 NURSING HOMES/LONG-TERM CARE FACILITIES
12.8.1 COMPRESSION WRAPS
12.8.2 SLEEVES AND GAUNTLETS
12.8.3 ADAPTIVE GARMENTS
13 NORTH AMERICA COMPRESSION THERAPY MARKET, BY REGION
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA COMPRESSION THERAPY MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMAPANY PROFILES
16.1 SOLVENTUM
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 CARDINAL HEALTH
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 SMITH+NEPHEW
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENT
16.4 ESSITY AKTIEBOLAG (PUBL)
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 PAUL HARTMANN AG
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENT
16.6 ADIDAS AG
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENT
16.7 AIROS MEDICAL, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 ARJO
16.8.1 COMPANY SNAPSHOT
16.8.2 REVENUE ANALYSIS
16.8.3 PRODUCT PORTFOLIO
16.8.4 RECENT DEVELOPMENTS
16.9 BAUERFEIND
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 BIOCOMPRESSION SYSTEMS
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 CALZE G.T.S.R.L
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 CONVATEC GROUP PLC
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 ENOVIS CORPORATION
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 BRAND PORTFOLIO
16.13.4 RECENT DEVELOPMENTS
16.14 GETINGE
16.14.1 COMPANY SNAPSHOT
16.14.2 REVENUE ANALYSIS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPMENT
16.15 HUNTLEIGH HEALTHCARE LIMITED
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 JUZO
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 LOHMANN & RAUSCHER GMBH & CO. KG
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 MCKESSON MEDICAL-SURGICAL INC.
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENT
16.19 MEDLINE INDUSTRIES, LP
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 MEDI GMBH & CO. KG
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 MEGO AFEK LTD.
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 MÖLNLYCKE AB
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENT
16.23 NIKE, INC.
16.23.1 COMPANY SNAPSHOT
16.23.2 REVENUE ANALYSIS
16.23.3 PRODUCT PORTFOLIO
16.23.4 RECENT DEVELOPMENT
16.24 OFA BAMBERG GMBH
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENT
16.25 ÖSSUR
16.25.1 COMPANY SNAPSHOT
16.25.2 RECENT FINANCIALS
16.25.3 PRODUCT PORTFOLIO
16.25.4 RECENT DEVELOPMENT
16.26 SIGVARIS GROUP
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENT
16.27 TACTILE MEDICAL
16.27.1 COMPANY SNAPSHOT
16.27.2 REVENUE ANALYSIS
16.27.3 PRODUCT PORTFOLIO
16.27.4 RECENT DEVELOPMENT
16.28 THERMOTEK
16.28.1 COMPANY SNAPSHOT
16.28.2 PRODUCT PORTFOLIO
16.28.3 RECENT DEVELOPMENT
16.29 THUASNE, SAS
16.29.1 COMPANY SNAPSHOT
16.29.2 PRODUCT PORTFOLIO
16.29.3 RECENT DEVELOPMENT
16.3 ZIMMER BIOMET
16.30.1 COMPANY SNAPSHOT
16.30.2 REVENUE ANALYSIS
16.30.3 PRODUCT PORTFOLIO
16.30.4 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
表格列表
TABLE 1 NORTH AMERICA COMPRESSION THERAPY MARKET, BY PRODUCT TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 2 NORTH AMERICA STATIC COMPRESSION THERAPY IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 3 NORTH AMERICA STATIC COMPRESSION THERAPY IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 4 NORTH AMERICA DYNAMIC COMPRESSION THERAPY IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 5 NORTH AMERICA DYNAMIC COMPRESSION THERAPY IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 6 NORTH AMERICA COMPRESSION THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 7 NORTH AMERICA COMPRESSION BANDAGES IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 8 NORTH AMERICA COMPRESSION BANDAGES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 9 NORTH AMERICA COMPRESSION GARMENTS FOR LYMPHEDEMA IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 10 NORTH AMERICA COMPRESSION GARMENTS FOR LYMPHEDEMA IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 11 NORTH AMERICA COMPRESSION STOCKINGS FOR VENOUS DISEASES IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 12 NORTH AMERICA COMPRESSION STOCKINGS FOR VENOUS DISEASES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 13 NORTH AMERICA COMPRESSION WRAPS IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 14 NORTH AMERICA PNEUMATIC COMPRESSION DEVICES IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 15 NORTH AMERICA COMPRESSION HOSIERY & GAUNTLETS IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 16 NORTH AMERICA COMPRESSION THERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 17 NORTH AMERICA VARICOSE VEINS IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 18 NORTH AMERICA LYMPHEDEMA IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 19 NORTH AMERICA CHRONIC VENOUS INSUFFICIENCY (CVI) IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 20 NORTH AMERICA DEEP VEIN THROMBOSIS (DVT) IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 21 NORTH AMERICA VENOUS LEG ULCERS IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 22 NORTH AMERICA WOUND CARE IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 23 NORTH AMERICA SPORTS INJURY MANAGEMENT IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 24 NORTH AMERICA COMPRESSION THERAPY MARKET, BY PATIENT GROUP, 2018-2032 (USD THOUSAND)
TABLE 25 NORTH AMERICA ADULT IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 26 NORTH AMERICA GERIATRIC IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 27 NORTH AMERICA PEDIATRIC IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 28 NORTH AMERICA COMPRESSION THERAPY MARKET, BY COMPRESSION LEVEL, 2018-2032 (USD THOUSAND)
TABLE 29 NORTH AMERICA MODERATE COMPRESSION IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 30 NORTH AMERICA STRONG COMPRESSION IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 31 NORTH AMERICA MILD COMPRESSION IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 32 NORTH AMERICA VERY STRONG COMPRESSION IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 33 NORTH AMERICA COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNELS, 2018-2032 (USD THOUSAND)
TABLE 34 NORTH AMERICA HOSPITALS IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 35 NORTH AMERICA HOSPITALS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 36 NORTH AMERICA RETAIL PHARMACIES IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 37 NORTH AMERICA RETAIL PHARMACIES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 38 NORTH AMERICA ECOMMERCE PLATFORMS IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 39 NORTH AMERICA ECOMMERCE PLATFORMS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 40 NORTH AMERICA SPECIALTY CLINICS IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 41 NORTH AMERICA SPECIALTY CLINICS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 42 NORTH AMERICA MEDICAL DEVICE STORES IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 43 NORTH AMERICA MEDICAL DEVICE STORES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 44 NORTH AMERICA HOME HEALTHCARE PROVIDERS IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 45 NORTH AMERICA HOME HEALTHCARE PROVIDERS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 46 NORTH AMERICA NURSING HOMES/LONG-TERM CARE FACILITIES IN COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 47 NORTH AMERICA NURSING HOMES/LONG-TERM CARE FACILITIES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 48 NORTH AMERICA COMPRESSION THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 49 NORTH AMERICA COMPRESSION THERAPY MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 50 NORTH AMERICA COMPRESSION THERAPY MARKET, BY PRODUCT TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 51 NORTH AMERICA STATIC COMPRESSION THERAPY IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 52 NORTH AMERICA DYNAMIC COMPRESSION THERAPY IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 53 NORTH AMERICA COMPRESSION THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 54 NORTH AMERICA COMPRESSION BANDAGES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 55 NORTH AMERICA COMPRESSION GARMENTS FOR LYMPHEDEMA IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 56 NORTH AMERICA COMPRESSION STOCKINGS FOR VENOUS DISEASES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 57 NORTH AMERICA COMPRESSION THERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 58 NORTH AMERICA COMPRESSION THERAPY MARKET, BY PATIENT GROUP, 2018-2032 (USD THOUSAND)
TABLE 59 NORTH AMERICA COMPRESSION THERAPY MARKET, BY COMPRESSION LEVEL, 2018-2032 (USD THOUSAND)
TABLE 60 NORTH AMERICA COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNELS, 2018-2032 (USD THOUSAND)
TABLE 61 NORTH AMERICA HOSPITALS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 62 NORTH AMERICA RETAIL PHARMACIES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 63 NORTH AMERICA ECOMMERCE PLATFORMS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 64 NORTH AMERICA SPECIALTY CLINICS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 65 NORTH AMERICA MEDICAL DEVICE STORES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 66 NORTH AMERICA HOME HEALTHCARE PROVIDERS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 67 NORTH AMERICA NURSING HOMES/LONG-TERM CARE FACILITIES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 68 U.S. COMPRESSION THERAPY MARKET, BY PRODUCT TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 69 U.S. STATIC COMPRESSION THERAPY IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 70 U.S. DYNAMIC COMPRESSION THERAPY IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 71 U.S. COMPRESSION THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 72 U.S. COMPRESSION BANDAGES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 73 U.S. COMPRESSION GARMENTS FOR LYMPHEDEMA IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 74 U.S. COMPRESSION STOCKINGS FOR VENOUS DISEASES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 75 U.S. COMPRESSION THERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 76 U.S. COMPRESSION THERAPY MARKET, BY PATIENT GROUP, 2018-2032 (USD THOUSAND)
TABLE 77 U.S. COMPRESSION THERAPY MARKET, BY COMPRESSION LEVEL, 2018-2032 (USD THOUSAND)
TABLE 78 U.S. COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNELS, 2018-2032 (USD THOUSAND)
TABLE 79 U.S. HOSPITALS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 80 U.S. RETAIL PHARMACIES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 81 U.S. ECOMMERCE PLATFORMS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 82 U.S. SPECIALTY CLINICS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 83 U.S. MEDICAL DEVICE STORES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 84 U.S. HOME HEALTHCARE PROVIDERS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 85 U.S. NURSING HOMES/LONG-TERM CARE FACILITIES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 86 CANADA COMPRESSION THERAPY MARKET, BY PRODUCT TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 87 CANADA STATIC COMPRESSION THERAPY IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 88 CANADA DYNAMIC COMPRESSION THERAPY IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 CANADA COMPRESSION THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 90 CANADA COMPRESSION BANDAGES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 91 CANADA COMPRESSION GARMENTS FOR LYMPHEDEMA IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 92 CANADA COMPRESSION STOCKINGS FOR VENOUS DISEASES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 93 CANADA COMPRESSION THERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 94 CANADA COMPRESSION THERAPY MARKET, BY PATIENT GROUP, 2018-2032 (USD THOUSAND)
TABLE 95 CANADA COMPRESSION THERAPY MARKET, BY COMPRESSION LEVEL, 2018-2032 (USD THOUSAND)
TABLE 96 CANADA COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNELS, 2018-2032 (USD THOUSAND)
TABLE 97 CANADA HOSPITALS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 98 CANADA RETAIL PHARMACIES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 99 CANADA ECOMMERCE PLATFORMS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 100 CANADA SPECIALTY CLINICS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 101 CANADA MEDICAL DEVICE STORES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 102 CANADA HOME HEALTHCARE PROVIDERS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 103 CANADA NURSING HOMES/LONG-TERM CARE FACILITIES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 104 MEXICO COMPRESSION THERAPY MARKET, BY PRODUCT TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 105 MEXICO STATIC COMPRESSION THERAPY IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 106 MEXICO DYNAMIC COMPRESSION THERAPY IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 107 MEXICO COMPRESSION THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 108 MEXICO COMPRESSION BANDAGES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 109 MEXICO COMPRESSION GARMENTS FOR LYMPHEDEMA IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 110 MEXICO COMPRESSION STOCKINGS FOR VENOUS DISEASES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 MEXICO COMPRESSION THERAPY MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 112 MEXICO COMPRESSION THERAPY MARKET, BY PATIENT GROUP, 2018-2032 (USD THOUSAND)
TABLE 113 MEXICO COMPRESSION THERAPY MARKET, BY COMPRESSION LEVEL, 2018-2032 (USD THOUSAND)
TABLE 114 MEXICO COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNELS, 2018-2032 (USD THOUSAND)
TABLE 115 MEXICO HOSPITALS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 116 MEXICO RETAIL PHARMACIES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 117 MEXICO ECOMMERCE PLATFORMS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 118 MEXICO SPECIALTY CLINICS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 119 MEXICO MEDICAL DEVICE STORES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 120 MEXICO HOME HEALTHCARE PROVIDERS IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 MEXICO NURSING HOMES/LONG-TERM CARE FACILITIES IN COMPRESSION THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
图片列表
FIGURE 1 NORTH AMERICA COMPRESSION THERAPY MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA COMPRESSION THERAPY MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA COMPRESSION THERAPY MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA COMPRESSION THERAPY MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA COMPRESSION THERAPY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA COMPRESSION THERAPY MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA COMPRESSION THERAPY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA COMPRESSION THERAPY MARKET: MARKET POSITION GRID
FIGURE 9 NORTH AMERICA COMPRESSION THERAPY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA COMPRESSION THERAPY MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 NORTH AMERICA COMPRESSION THERAPY MARKET: SEGMENTATION
FIGURE 12 NORTH AMERICA COMPRESSION THERAPY MARKET: EXECUTIVE SUMMARY
FIGURE 13 NORTH AMERICA COMPRESSION THERAPY MARKET: STRATEGIC DECISIONS
FIGURE 14 RISING PREVALENCE OF CHRONIC VENOUS DISORDERS GLOBALLY IS EXPECTED TO DRIVE THE NORTH AMERICA COMPRESSION THERAPY MARKET IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 15 STATIC COMPRESSION THERAPY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA COMPRESSION THERAPY MARKET IN THE FORECAST PERIOD OF 2025 & 2032
FIGURE 16 TWO SEGMENT COMPRISE THE NORTH AMERICA COMPRESSION THERAPY MARKET, BY PRODUCT TECHNIQUE (2024)
FIGURE 17 DISTRIBUTION OF PATENTS BY IPC CODE
FIGURE 18 REGION-WISE DISTRIBUTION OF PATENTS
FIGURE 19 NUMBER OF PATENTS BY APPLICANT
FIGURE 20 ANNUAL PATENT PUBLICATIONS
FIGURE 21 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA COMPRESSION THERAPY MARKET
FIGURE 22 NORTH AMERICA COMPRESSION THERAPY MARKET: BY PRODUCT TECHNIQUE, 2024
FIGURE 23 NORTH AMERICA COMPRESSION THERAPY MARKET: BY PRODUCT TECHNIQUE, 2025 TO 2032 (USD THOUSAND)
FIGURE 24 NORTH AMERICA COMPRESSION THERAPY MARKET: BY PRODUCT TECHNIQUE, CAGR (2025-2032)
FIGURE 25 NORTH AMERICA COMPRESSION THERAPY MARKET: BY PRODUCT TECHNIQUE, LIFELINE CURVE
FIGURE 26 NORTH AMERICA COMPRESSION THERAPY MARKET: BY PRODUCT TYPE, 2024
FIGURE 27 NORTH AMERICA COMPRESSION THERAPY MARKET: BY PRODUCT TYPE, 2025 TO 2032 (USD THOUSAND)
FIGURE 28 NORTH AMERICA COMPRESSION THERAPY MARKET: BY PRODUCT TYPE, CAGR (2025-2032)
FIGURE 29 NORTH AMERICA COMPRESSION THERAPY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 30 NORTH AMERICA COMPRESSION THERAPY MARKET: BY APPLICATION, 2024
FIGURE 31 NORTH AMERICA COMPRESSION THERAPY MARKET: BY APPLICATION, 2025 TO 2032 (USD THOUSAND)
FIGURE 32 NORTH AMERICA COMPRESSION THERAPY MARKET: BY APPLICATION, CAGR (2025-2032)
FIGURE 33 NORTH AMERICA COMPRESSION THERAPY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 34 NORTH AMERICA COMPRESSION THERAPY MARKET: BY PATIENT GROUP, 2024
FIGURE 35 NORTH AMERICA COMPRESSION THERAPY MARKET: BY PATIENT GROUP, 2025 TO 2032 (USD THOUSAND)
FIGURE 36 NORTH AMERICA COMPRESSION THERAPY MARKET: BY PATIENT GROUP, CAGR (2025-2032)
FIGURE 37 NORTH AMERICA COMPRESSION THERAPY MARKET: BY PATIENT GROUP, LIFELINE CURVE
FIGURE 38 NORTH AMERICA COMPRESSION THERAPY MARKET: BY COMPRESSION LEVEL, 2024
FIGURE 39 NORTH AMERICA COMPRESSION THERAPY MARKET: BY COMPRESSION LEVEL, 2025 TO 2032 (USD THOUSAND)
FIGURE 40 NORTH AMERICA COMPRESSION THERAPY MARKET: BY COMPRESSION LEVEL, CAGR (2025-2032)
FIGURE 41 NORTH AMERICA COMPRESSION THERAPY MARKET: BY COMPRESSION LEVEL, LIFELINE CURVE
FIGURE 42 NORTH AMERICA COMPRESSION THERAPY MARKET: BY DISTRIBUTION CHANNELS, 2024
FIGURE 43 NORTH AMERICA COMPRESSION THERAPY MARKET: BY DISTRIBUTION CHANNELS, 2025 TO 2032 (USD THOUSAND)
FIGURE 44 NORTH AMERICA COMPRESSION THERAPY MARKET: BY DISTRIBUTION CHANNELS, CAGR (2025-2032)
FIGURE 45 NORTH AMERICA COMPRESSION THERAPY MARKET: BY DISTRIBUTION CHANNELS, LIFELINE CURVE
FIGURE 46 NORTH AMERICA COMPRESSION THERAPY MARKET: SNAPSHOT (2024)
FIGURE 47 NORTH AMERICA COMPRESSION THERAPY MARKET: COMPANY SHARE 2024 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
